MAPT and Alzheimer disease: To quantify the seeding ability of h-AD in this model, h-AD (Supplementary Fig. 5B and F) or PBS (Supplementary Fig. 5C and G) were injected into the CA1 layer of Tg30tau mice and the appearance of tau pathology was evaluated 5 weeks post-injection by immunohistochemistry.